603590 康辰药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.3435.0273.4914.9606.316
总资产报酬率 ROA (%)1.0864.1762.9874.1355.269
投入资产回报率 ROIC (%)1.2614.8423.4264.8286.134

边际利润分析
销售毛利率 (%)88.72989.01785.44486.94092.673
营业利润率 (%)25.22715.57416.23423.74625.997
息税前利润/营业总收入 (%)24.70012.09514.12920.43319.767
净利润/营业总收入 (%)23.51220.38814.29520.67722.674

收益指标分析
经营活动净收益/利润总额(%)96.623119.22499.25972.60175.534
价值变动净收益/利润总额(%)1.0173.825-5.45018.8736.099
营业外收支净额/利润总额(%)0.001-16.744-0.276-1.820-1.057

偿债能力分析
流动比率 (X)3.2273.8035.8996.1243.039
速动比率 (X)3.0843.6535.6845.8202.982
资产负债率 (%)11.27111.0676.8527.14118.536
带息债务/全部投入资本 (%)4.6964.093-0.584-0.715-0.280
股东权益/带息债务 (%)1,991.2822,304.434-16,868.760-13,673.838-34,575.586
股东权益/负债合计 (%)717.066731.2771,246.7891,199.940438.682
利息保障倍数 (X)-46.785-9.710-6.856-7.073-3.318

营运能力分析
应收账款周转天数 (天)116.827105.785106.06490.84586.988
存货周转天数 (天)193.389152.229119.869137.797146.421